Abstract
In 2007, the European dental biomaterial market exceeded $140 million.
This market is comprised of dental bone graft substitutes (BGS), tissue
regeneration materials, and dental membranes in Germany, France, Italy, Spain,
Switzerland, Sweden, and the UK.